Ability of Adults to Correctly Use Grey Market Peptide Semaglutide GLP-1 Receptor Agonists Acquired Without a Prescription
Public Health Reports® · 01.08.2026
DOI: 10.1177/00333549261464876 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health Reports®, online erschienen am 01.08.2026. Verfasst von Ava Sedensky und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, University of Connecticut School of Pharmacy and Pharmaceutical Sciences, Storrs, CT, USA. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: university of connecticut.
Abstract (Originalsprache)
A legal loophole allows consumers to purchase peptide semaglutide without a prescription, but websites that sell them do not sell supplies or provide guidance. We assessed the ability and confidence of college students at the University of Connecticut and older adults in performing the required steps from September 1, 2025, through January 30, 2026. Participants looked up information online. We provided various semaglutide and diluent vials and supplies. We assessed 34 steps in the process and assigned 1 point for each step successfully completed. We rated confidence on a scale from 1 (no confidence) to 5 (complete confidence). We evaluated 20 adults aged ≥18 years (12 male, 8 female) with a mean (SD) age of 40 (21) years. Participants completed 15 of the 34 steps correctly (mean [SD] = 44% [50%]). We found errors that could result in incorrect dosing, needle sticks, or infections. Mean (SD) confidence was low before and after the demonstration but not significantly so (2.3 [0.7] vs 1.9 [1.0]; P = .19). Untrained adults without experience injecting medications could be at high risk of adverse events when they try to self-administer grey market peptide semaglutide products using only internet information. Future studies should assess a larger and more diverse population and determine whether the results are similar with other products sold as peptides without a prescription.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Practice, University of Connecticut School of Pharmacy and Pharmaceutical Sciences, Storrs, CT, USA.
ORCID-Profile: C Michael White
Förderung
- university of connecticut
Zitieren
APA
Sedensky, A., Nuzi, K., Nolan, L., Belcourt, J., & White, C. M. (2026). Ability of Adults to Correctly Use Grey Market Peptide Semaglutide GLP-1 Receptor Agonists Acquired Without a Prescription. Public Health Reports®. https://doi.org/10.1177/00333549261464876
Vancouver
Sedensky A, Nuzi K, Nolan L, Belcourt J, White CM. Ability of Adults to Correctly Use Grey Market Peptide Semaglutide GLP-1 Receptor Agonists Acquired Without a Prescription. Public Health Reports®. 2026. doi:10.1177/00333549261464876
BibTeX
@article{Sedensky2026,
author = {Sedensky, Ava and Nuzi, Klaus and Nolan, Laura and Belcourt, Jordyn and White, C Michael},
title = {Ability of Adults to Correctly Use Grey Market Peptide Semaglutide GLP-1 Receptor Agonists Acquired Without a Prescription},
journal = {Public Health Reports®},
year = {2026},
doi = {10.1177/00333549261464876}
}
EUVIMED